![conference banner](/images/conference-banner.jpeg)
Abstract
Background and Objectives: Resveratrol is a promising drug for tumor therapy, but its anti-tumor mechanism remains unclarified. The present study aimed to explore the effect of resveratrol on the secretion of exosomes and the role of resveratrol-induced exosomes in the progression of hepatocellular carcinoma.
Methods: The number and contents of exosomes induced by resveratrol were determined by nanoparticle tracking analysis and high-throughput sequencing in Huh7 cells, respectively. Expression of Rab27a was assessed by Western blotting and immunofluorescence. Cell proliferation, migration and epithelial-mesenchymal transition were examined with the stimuli of resveratrol and exosomes, the activity of autophagy and wnt/β-catenin signaling induced by resveratrol-induced exosomes and knockdown of lncRNA SNHG29 were monitored by Western blotting and immunofluorescence.
Results: It was found that resveratrol might inhibit the exosome secretion by down-regulating the expression of Rab27a, thereby suppressing the proliferation, migration and epithelial-mesenchymal transition of Huh7 cells. Moreover, resveratrol-induced exosomes could also inhibit the malignant phenotype of Huh7 cells via inhibiting the nuclear translocation of β-catenin and the activation of autophagy, which lncRNA SNHG29 might mediate.
Conclusion: Resveratrol inhibits hepatocellular carcinoma progression by regulating exosome secretion and contents.
Keywords: Hepatocellular carcinoma, resveratrol, exosome, autophagy, lncRNA, nano-particle.
[http://dx.doi.org/10.1056/NEJMra1001683] [PMID: 21992124]
[http://dx.doi.org/10.3390/ijms222413424] [PMID: 34948230]
[http://dx.doi.org/10.2174/1875533XMTAyiOTQi2] [PMID: 31830882]
[http://dx.doi.org/10.3390/molecules27092665] [PMID: 35566016]
[http://dx.doi.org/10.1016/j.bbcan.2019.04.004] [PMID: 31047959]
[http://dx.doi.org/10.1038/ncb2000]
[http://dx.doi.org/10.1007/s11010-020-03945-x] [PMID: 33095380]
[http://dx.doi.org/10.3389/fonc.2021.644134] [PMID: 33937049]
[http://dx.doi.org/10.1146/annurev-biochem-013118-111902] [PMID: 31220978]
[http://dx.doi.org/10.1038/s41467-019-09720-x] [PMID: 30967557]
[http://dx.doi.org/10.1002/ijc.32064] [PMID: 30556600]
[http://dx.doi.org/10.1186/s12943-019-1085-0] [PMID: 31901224]
[http://dx.doi.org/10.3390/cells11121946] [PMID: 35741075]
[http://dx.doi.org/10.1016/j.omtn.2022.01.009] [PMID: 35317280]
[http://dx.doi.org/10.1016/j.canlet.2020.02.003] [PMID: 32112905]
[http://dx.doi.org/10.1186/s12943-019-0982-6] [PMID: 30925935]
[http://dx.doi.org/10.1038/onc.2016.353] [PMID: 27669441]
[http://dx.doi.org/10.1111/cas.13310] [PMID: 28667694]
[http://dx.doi.org/10.1186/s12943-017-0714-8] [PMID: 28841829]
[http://dx.doi.org/10.1186/s12964-018-0315-1] [PMID: 30616541]
[http://dx.doi.org/10.1186/s12943-019-0990-6] [PMID: 30943982]
[http://dx.doi.org/10.1038/s41419-018-0534-9] [PMID: 29725020]
[http://dx.doi.org/10.3390/cells8020091] [PMID: 30695997]
[http://dx.doi.org/10.1186/s12935-021-01825-y] [PMID: 33663509]
[http://dx.doi.org/10.1089/cbr.2020.3578] [PMID: 32799541]
![Wayfinder Image](/images/wayfinder.jpg)